ASSSSMENT OF A NEW COMMERCIAL 3 WAVELENGTH OXIMETER

这个子项目是许多利用资源的研究子项目之一 由NIH/NCRR资助的中心拨款提供。子项目的主要支持 而子项目的主要调查员可能是由其他来源提供的， 包括其它NIH来源。 列出的子项目总成本可能 代表子项目使用的中心基础设施的估计数量， 而不是由NCRR赠款提供给子项目或子项目工作人员的直接资金。 Hamamatsu Photonics开发了一种原型双通道时域组织血氧仪。 Hamamatsu目前正在搜索该设备可能使用的应用。 将评估仪器信噪比、稳定性、用户和患者界面以及整体系统性能的测试。

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. Primary support for the subproject and the subproject's principal investigator may have been provided by other sources, including other NIH sources. The Total Cost listed for the subproject likely represents the estimated amount of Center infrastructure utilized by the subproject, not direct funding provided by the NCRR grant to the subproject or subproject staff. Hamamatsu Photonics has developed a prototype dual channel time domain tissue oximeter. Hamamatsu is currently searching for applications for which this device may be used. Tests of instrument signal-to-noise, stability, user and patient interfaces, and overall system performance will be assessed.